Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6490397

CCOC(=O)CN1CCc2ccc(C(N)=O)cc21.NCc1cccc(C(=O)N(CC(=O)O)c2ccccc2)c1.O=C(O)C(F)(F)F

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F2 P00734 5/20 0.37
F10 P00742 3/20 0.37
ITGB3 P05106 2/20 0.37
ITGA2B P08514 2/20 0.37
OPRD1 P41143 6/20 0.34
OPRM1 P35372 4/20 0.34
OPRK1 P41145 1/20 0.33
LMNA P02545 1/20 0.33
TP53 P04637 1/20 0.33
MAPT P10636 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
AOC3 Q16853 2/20 0.33
KLK1 P06870 1/20 0.33
ACHE P22303 1/20 0.33
LOXL2 Q9Y4K0 1/20 0.32
ADAMTS4 O75173 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5210452 0.94 OPRM1 (0.35) F2F10ITGB3ITGA2BOPRD1
Trifluoroacetic Acid SCHEMBL5214432 0.89 ACHE (0.42) OPRD1OPRM1OPRK1CYP2C19ACHE
Trifluoroacetic Acid SCHEMBL5245608 0.86 OPRM1 (0.36) F2F10OPRD1OPRM1OPRK1
Trifluoroacetic Acid SCHEMBL5215547 0.85 RIPK1 (0.36) F2F10OPRD1OPRM1OPRK1
Trifluoroacetic Acid SCHEMBL5211441 0.85 RIPK1 (0.38) F2F10OPRD1OPRM1OPRK1
Trifluoroacetic Acid SCHEMBL5210720 0.85 HSD17B3 (0.38) MAPTALDH1A1
Trifluoroacetic Acid SCHEMBL5209869 0.85 OPRD1 (0.34) F2F10OPRD1OPRM1OPRK1
Trifluoroacetic Acid SCHEMBL5629383 0.85 POLB (0.36) F2OPRD1OPRM1OPRK1TP53
Trifluoroacetic Acid SCHEMBL5211445 0.84 POLB (0.44) F2F10OPRD1OPRM1MAPT
Trifluoroacetic Acid SCHEMBL5212450 0.84 RIPK1 (0.39) F2F10OPRD1OPRM1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6916957-B2 Serine protease inhibitors TULARIK LIMITED (GB) 2005-07-12 US disclosed
US-20030018059-A1 Serine protease inhibitors PROTHERICS MOLECULAR DESIGN LIMITED (GB) 2003-01-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030018059-A1 Serine protease inhibitors TPSAB1, PRSS1, SERPINB1 F2 122/4885F10 149/4885ITGB3 2185/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.